Tobias Raum

Person

Munich, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3
- Patent number 12,152,078
- Issue date Nov 26, 2024
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific single domain bispecific single chain antibody
- Patent number 11,987,633
- Issue date May 21, 2024
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions comprising cross-species-specific antibodies and uses...
- Patent number 11,925,684
- Issue date Mar 12, 2024
- Amgen Research (Munich) GmbH
- Roman Kischel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody constructs for CDH3 and CD3
- Patent number 11,926,666
- Issue date Mar 12, 2024
- Amgen Research (Munich) GmbH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for MSLN and CD3
- Patent number 11,884,720
- Issue date Jan 30, 2024
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for CLDN18.2 and CD3
- Patent number 11,692,031
- Issue date Jul 4, 2023
- Amgen Research (Munich) GmbH
- Christoph Dahlhoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized cross-species specific bispecific single chain antibody c...
- Patent number 11,661,462
- Issue date May 30, 2023
- Amgen Research (Munich) GmbH
- Benno Rattel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for DLL3 and CD3
- Patent number 11,591,396
- Issue date Feb 28, 2023
- Amgen Research (Munich) GmbH
- Tobias Raum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 11,498,964
- Issue date Nov 15, 2022
- Amgen Research (Munich) GmbH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific PSMAxCD3 bispecific single chain antibody
- Patent number 11,472,886
- Issue date Oct 18, 2022
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for FLT3 and CD3
- Patent number 11,447,567
- Issue date Sep 20, 2022
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific T cell engaging antibody constructs
- Patent number 11,434,302
- Issue date Sep 6, 2022
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCMA and CD3 bispecific T cell engaging antibody constructs
- Patent number 11,352,433
- Issue date Jun 7, 2022
- Amgen Research (Munich) GmbH
- Tobias Raum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for treating glioblastoma or glioma with antibody constructs...
- Patent number 11,155,629
- Issue date Oct 26, 2021
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibody constructs for CDH3 and CD3
- Patent number 11,028,171
- Issue date Jun 8, 2021
- Amgen Research (Munich) GmbH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cross-species-specific single domain bispecific single chain antibody
- Patent number 10,981,998
- Issue date Apr 20, 2021
- Amgen Research (Munich) GmbH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for CD70 and CD3
- Patent number 10,851,170
- Issue date Dec 1, 2020
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PSMA and CD3 bispecific T cell engaging antibody constructs
- Patent number 10,781,264
- Issue date Sep 22, 2020
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 10,766,969
- Issue date Sep 8, 2020
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 10,752,694
- Issue date Aug 25, 2020
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for DLL3 and CD3
- Patent number 10,683,351
- Issue date Jun 16, 2020
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for EGFRVIII and CD3
- Patent number 10,519,241
- Issue date Dec 31, 2019
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BCMA and CD3 bispecific T cell engaging antibody constructs
- Patent number 10,301,391
- Issue date May 28, 2019
- Amgen Research (Munich) GmbH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for DLL3 and CD3
- Patent number 10,294,300
- Issue date May 21, 2019
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody neutralizers of human granulocyte macrophage colony stimul...
- Patent number 10,138,297
- Issue date Nov 27, 2018
- Amgen Research (Munich) GmbH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 10,059,766
- Issue date Aug 28, 2018
- Amgen Inc.
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 9,982,063
- Issue date May 29, 2018
- Amgen Research (Munich) GmbH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody constructs for CDH19 and CD3
- Patent number 9,765,157
- Issue date Sep 19, 2017
- Amgen Research (Munich) GmbH
- Shouhua Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions with resistance to soluble CEA
- Patent number 9,695,250
- Issue date Jul 4, 2017
- Amgen Research (Munich) GmbH
- Ralf Lutterbüse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules for BCMA and CD3
- Patent number 9,598,500
- Issue date Mar 21, 2017
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY CONSTRUCTS FOR MSLN AND CD3
- Publication number 20240400673
- Publication date Dec 5, 2024
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 AND CD22 TARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIF...
- Publication number 20240384006
- Publication date Nov 21, 2024
- AMGEN RESEARCH (MUNICH) GMBH
- Marc Panzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SE...
- Publication number 20240209078
- Publication date Jun 27, 2024
- Amgen Inc.
- Stephanie Everts
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Constructs for CLDN18.2 and CD3
- Publication number 20240174745
- Publication date May 30, 2024
- AMGEN RESEARCH (MUNICH) GMBH
- Christoph Dahlhoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibody Constructs for CDH19 and CD3
- Publication number 20240010724
- Publication date Jan 11, 2024
- Amgen Inc.
- Shouhua Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDE CONSTRUCTS BINDING TO CD3
- Publication number 20230406929
- Publication date Dec 21, 2023
- Amgen Inc.
- Doris Rau
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC BINDING DOMAIN
- Publication number 20230357444
- Publication date Nov 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONSTRUCTS FOR DLL3 AND CD3
- Publication number 20230312717
- Publication date Oct 5, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODY CONSTRUCTS FOR FLT3 AND CD3
- Publication number 20230272113
- Publication date Aug 31, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS
- Publication number 20230192884
- Publication date Jun 22, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LONG LIFE POLYPEPTIDE BINDING MOLECULES
- Publication number 20230057728
- Publication date Feb 23, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20230037742
- Publication date Feb 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3
- Publication number 20230041876
- Publication date Feb 9, 2023
- AMGEN RESEARCH (MUNICH) GMBH
- Bertram Weiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCR8 ANTIBODIES AND USES THEREOF
- Publication number 20220403037
- Publication date Dec 22, 2022
- Amgen Inc.
- NATHAN WILLIAM PIERCE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220356268
- Publication date Nov 10, 2022
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220251243
- Publication date Aug 11, 2022
- Amgen Inc.
- Peter Kufer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING GLIOBLASTOMA OR GLIOMA WITH ANITBODY CONSTRUCTS...
- Publication number 20220064308
- Publication date Mar 3, 2022
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES FOR BCMA AND CD3
- Publication number 20220064336
- Publication date Mar 3, 2022
- Amgen Inc.
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC SINGLE DOMAIN BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20220041736
- Publication date Feb 10, 2022
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MAGEB2 BINDING CONSTRUCTS
- Publication number 20220017636
- Publication date Jan 20, 2022
- Amgen Inc.
- Ian Nevin FOLTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONSTRUCTS FOR DLL3 AND CD3
- Publication number 20210309743
- Publication date Oct 7, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONSTRUCTS FOR CD70 AND CD3
- Publication number 20210284748
- Publication date Sep 16, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20210277143
- Publication date Sep 9, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
- Publication number 20210269550
- Publication date Sep 2, 2021
- AMGEN RESEARCH (MUNICH) GMBH
- Peter KUFER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Antibody Construct Directed to MUC17 and CD3
- Publication number 20210130465
- Publication date May 6, 2021
- Amgen Inc.
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs
- Publication number 20210070878
- Publication date Mar 11, 2021
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD...
- Publication number 20200362039
- Publication date Nov 19, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONSTRUCTS FOR DLL3 AND CD3
- Publication number 20200332002
- Publication date Oct 22, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3
- Publication number 20200140558
- Publication date May 7, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Tobias Raum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
- Publication number 20200095319
- Publication date Mar 26, 2020
- AMGEN RESEARCH (MUNICH) GMBH
- Peter Kufer
- C07 - ORGANIC CHEMISTRY

Tobias Raum

Person

Patents Grantslast 30 patents

Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3

Cross-species-specific single domain bispecific single chain antibody

Compositions comprising cross-species-specific antibodies and uses...

Bispecific antibody constructs for CDH3 and CD3

Antibody constructs for MSLN and CD3

Antibody constructs for CLDN18.2 and CD3

Optimized cross-species specific bispecific single chain antibody c...

Antibody constructs for DLL3 and CD3

Antibody constructs for CDH19 and CD3

Cross-species-specific PSMAxCD3 bispecific single chain antibody

Antibody constructs for FLT3 and CD3

Bispecific T cell engaging antibody constructs

BCMA and CD3 bispecific T cell engaging antibody constructs

Method for treating glioblastoma or glioma with antibody constructs...

Bispecific antibody constructs for CDH3 and CD3

Cross-species-specific single domain bispecific single chain antibody

Antibody constructs for CD70 and CD3

PSMA and CD3 bispecific T cell engaging antibody constructs

Binding molecules for BCMA and CD3

Binding molecules for BCMA and CD3

Antibody constructs for DLL3 and CD3

Antibody constructs for EGFRVIII and CD3

BCMA and CD3 bispecific T cell engaging antibody constructs

Antibody constructs for DLL3 and CD3

Antibody neutralizers of human granulocyte macrophage colony stimul...

Antibody constructs for CDH19 and CD3

Pharmaceutical compositions with resistance to soluble CEA

Antibody constructs for CDH19 and CD3

Pharmaceutical compositions with resistance to soluble CEA

Binding molecules for BCMA and CD3

Patents Applicationslast 30 patents

ANTIBODY CONSTRUCTS FOR MSLN AND CD3

CD20 AND CD22 TARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIF...

MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SE...

Antibody Constructs for CLDN18.2 and CD3

Antibody Constructs for CDH19 and CD3

POLYPEPTIDE CONSTRUCTS BINDING TO CD3

CROSS-SPECIES-SPECIFIC BINDING DOMAIN

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

ANTIBODY CONSTRUCTS FOR FLT3 AND CD3

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

LONG LIFE POLYPEPTIDE BINDING MOLECULES

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

ANTI-CCR8 ANTIBODIES AND USES THEREOF

BINDING MOLECULES FOR BCMA AND CD3

BINDING MOLECULES FOR BCMA AND CD3

METHOD FOR TREATING GLIOBLASTOMA OR GLIOMA WITH ANITBODY CONSTRUCTS...

BINDING MOLECULES FOR BCMA AND CD3

CROSS-SPECIES-SPECIFIC SINGLE DOMAIN BISPECIFIC SINGLE CHAIN ANTIBODY

MAGEB2 BINDING CONSTRUCTS

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

ANTIBODY CONSTRUCTS FOR CD70 AND CD3

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

Bispecific Antibody Construct Directed to MUC17 and CD3

PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs

CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD...

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

ANTIBODY CONSTRUCTS FOR EGFRVIII AND CD3

CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS